Skip to main content
Erschienen in: Annals of Hematology 3/2008

01.03.2008 | Letter to the Editor

Long-term propylthiouracil use and acute myeloid leukemia: A case report and review of the literature

verfasst von: Daniele Focosi, Francesco Caracciolo, Sara Galimberti, Federico Papineschi, Mario Petrini

Erschienen in: Annals of Hematology | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …
Literatur
1.
Zurück zum Zitat Aycan Z, Arhan E, Çetinkaya E, Vidinlisan S, Menekse N, Yücel H, Cakar N (2006) Propylthiouracil-induced hypersensitivity syndrome. Turk J Pediatr 48:162–165PubMed Aycan Z, Arhan E, Çetinkaya E, Vidinlisan S, Menekse N, Yücel H, Cakar N (2006) Propylthiouracil-induced hypersensitivity syndrome. Turk J Pediatr 48:162–165PubMed
2.
Zurück zum Zitat Gungor KGS, Kisakol GDO, Kaya A (2006) ANCA positive propylthiouracil induced pyoderma gangrenosum. J Endocrinol Invest 29:575–576PubMed Gungor KGS, Kisakol GDO, Kaya A (2006) ANCA positive propylthiouracil induced pyoderma gangrenosum. J Endocrinol Invest 29:575–576PubMed
3.
Zurück zum Zitat Sheen Y, Chu C, Yu H (2006) Antineutrophil cytoplasmic antibody-positive cutaneous leukocytoclastic vasculitis associated with propylthiouracil therapy. Arch Dermatol 142:879–880PubMedCrossRef Sheen Y, Chu C, Yu H (2006) Antineutrophil cytoplasmic antibody-positive cutaneous leukocytoclastic vasculitis associated with propylthiouracil therapy. Arch Dermatol 142:879–880PubMedCrossRef
4.
Zurück zum Zitat Cetina J, Fishbein E-SD (1972) Antinuclear antibodies and propylthiouracil therapy. JAMA 220:1012PubMedCrossRef Cetina J, Fishbein E-SD (1972) Antinuclear antibodies and propylthiouracil therapy. JAMA 220:1012PubMedCrossRef
5.
Zurück zum Zitat Bistrom O (1950) The effect of methyl- and propylthiouracil on the histology of the thyroid and pituitary and on the bone marrow in rats. Ann Med Exp Biol Fenn 28:1–21PubMedCrossRef Bistrom O (1950) The effect of methyl- and propylthiouracil on the histology of the thyroid and pituitary and on the bone marrow in rats. Ann Med Exp Biol Fenn 28:1–21PubMedCrossRef
6.
Zurück zum Zitat Futcher P, Massie E (1950) Agranulocytosis due to propylthiouracil. Ann Intern Med 32:137PubMed Futcher P, Massie E (1950) Agranulocytosis due to propylthiouracil. Ann Intern Med 32:137PubMed
7.
Zurück zum Zitat De La Balze F, Celani Barry R, Arrillaga F, Mancini R (1952) Effect of methylthiouracil and propylthiouracil on the number of circulatory eosinophils and eosinopoiesis in the bone marrow in hyperthyroidism and in normal subjects. Medicina (B Aires) 12:1–16 De La Balze F, Celani Barry R, Arrillaga F, Mancini R (1952) Effect of methylthiouracil and propylthiouracil on the number of circulatory eosinophils and eosinopoiesis in the bone marrow in hyperthyroidism and in normal subjects. Medicina (B Aires) 12:1–16
8.
Zurück zum Zitat Lipsky J, Gallego M (1988) Mechanism of thionamide antithyroid drug associated hypoprothrombinemia. Drug Metabol Drug Interact 6:317–326PubMed Lipsky J, Gallego M (1988) Mechanism of thionamide antithyroid drug associated hypoprothrombinemia. Drug Metabol Drug Interact 6:317–326PubMed
9.
Zurück zum Zitat Akarsu E, Buyukhatipoglu H, Aktaran SGR (2006) Propylthiouracil-related hemorrhagic diathesis: a case report and review of the literature. Mt Sinai J Med 73 Akarsu E, Buyukhatipoglu H, Aktaran SGR (2006) Propylthiouracil-related hemorrhagic diathesis: a case report and review of the literature. Mt Sinai J Med 73
10.
Zurück zum Zitat Sammon T, Peden V, Witzleben C, King J (1971) Disseminated intravascular coagulation complicating propylthiouracil therapy. A case description of a 16-year-old girl. Clin Pediatr (Phila) 10:739–742CrossRef Sammon T, Peden V, Witzleben C, King J (1971) Disseminated intravascular coagulation complicating propylthiouracil therapy. A case description of a 16-year-old girl. Clin Pediatr (Phila) 10:739–742CrossRef
11.
Zurück zum Zitat Fewell R, Engel E, Zimmerman S (1950) Acute thrombopenic purpura associated with administration of propylthiouracil. J Am Med Assoc 143:891–892PubMed Fewell R, Engel E, Zimmerman S (1950) Acute thrombopenic purpura associated with administration of propylthiouracil. J Am Med Assoc 143:891–892PubMed
12.
Zurück zum Zitat Martelo O, Katims R, Yunis A (1967) Bone marrow aplasia following propylthiouracil therapy. Report of a case with complete recovery. Arch Intern Med 120:587–590PubMedCrossRef Martelo O, Katims R, Yunis A (1967) Bone marrow aplasia following propylthiouracil therapy. Report of a case with complete recovery. Arch Intern Med 120:587–590PubMedCrossRef
14.
Zurück zum Zitat Aksoy M, Erdem S, Tezel H, Tezel T (1974) Letter: acute myeloblastic leukaemia after propylthiouracil. Lancet 1:928–929PubMedCrossRef Aksoy M, Erdem S, Tezel H, Tezel T (1974) Letter: acute myeloblastic leukaemia after propylthiouracil. Lancet 1:928–929PubMedCrossRef
15.
Zurück zum Zitat Azizerli H, Aksoy M, Alagol F (1988) Acute myeloblastic leukemia after propyl-thio-uracil, a simple coincidence? Acta Haematol 79:229PubMedCrossRef Azizerli H, Aksoy M, Alagol F (1988) Acute myeloblastic leukemia after propyl-thio-uracil, a simple coincidence? Acta Haematol 79:229PubMedCrossRef
16.
Zurück zum Zitat Larson R (2007) Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia? Best Pract Res Clin Haematol 20:29–37PubMedCrossRef Larson R (2007) Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia? Best Pract Res Clin Haematol 20:29–37PubMedCrossRef
17.
Zurück zum Zitat Richkind K, Hromas R, Lytle C, Crenshaw D, Velasco J, Roherty S, Srinivasiah J, Varella-Garcia M (2000) Identification of two new translocations that disrupt the AML1 gene. Cancer Genet Cytogenet 122:141–143PubMedCrossRef Richkind K, Hromas R, Lytle C, Crenshaw D, Velasco J, Roherty S, Srinivasiah J, Varella-Garcia M (2000) Identification of two new translocations that disrupt the AML1 gene. Cancer Genet Cytogenet 122:141–143PubMedCrossRef
18.
Zurück zum Zitat Izumi T, Ohtsuki T, Ohya KOY, Yoshida M, Muroi K, Imagawa SHK, Kuriki K, Saito K, Miura Y (1996) Therapy-related leukemia with a novel 21q22 rearrangement. Cancer Genet Cytogenet 90:45–48PubMedCrossRef Izumi T, Ohtsuki T, Ohya KOY, Yoshida M, Muroi K, Imagawa SHK, Kuriki K, Saito K, Miura Y (1996) Therapy-related leukemia with a novel 21q22 rearrangement. Cancer Genet Cytogenet 90:45–48PubMedCrossRef
19.
Zurück zum Zitat Schlaifer D, Cooper M, Attal M, Rousseau A, Pris J, Laurent G, Myers C (1994) Potential strategies for circumventing myeloperoxidase-catalyzed degradation of vinca alkaloids. Leukemia 8:668–671PubMed Schlaifer D, Cooper M, Attal M, Rousseau A, Pris J, Laurent G, Myers C (1994) Potential strategies for circumventing myeloperoxidase-catalyzed degradation of vinca alkaloids. Leukemia 8:668–671PubMed
20.
Zurück zum Zitat Lee E, Kariya K (1986) Propylthiouracil, a selective inhibitor of NADH-cytochrome b5 reductase. FEBS Lett 209:49–51PubMedCrossRef Lee E, Kariya K (1986) Propylthiouracil, a selective inhibitor of NADH-cytochrome b5 reductase. FEBS Lett 209:49–51PubMedCrossRef
21.
Zurück zum Zitat Kurian JR, Bajad SU, Miller JL, Chin NA, Trepanier LA (2004) NADH cytochrome b5 reductase and cytochrome b5 catalyze the microsomal reduction of xenobiotic hydroxylamines and amidoximes in humans. J Pharmacol Exp Ther 311:1171–1178PubMedCrossRef Kurian JR, Bajad SU, Miller JL, Chin NA, Trepanier LA (2004) NADH cytochrome b5 reductase and cytochrome b5 catalyze the microsomal reduction of xenobiotic hydroxylamines and amidoximes in humans. J Pharmacol Exp Ther 311:1171–1178PubMedCrossRef
22.
Zurück zum Zitat Saulter JY, Kurian JR, Trepanier LA, Tidwell RR, Bridges AS, Boykin DW, Stephens CE, Anbazhagan M, Hall JE (2005) Unusual dehydroxylation of antimicrobial amidoxime prodrugs by cytochrome b5 and NADH cytochrome b5 reductase. Drug Metab Dispos 33:1886–1893PubMed Saulter JY, Kurian JR, Trepanier LA, Tidwell RR, Bridges AS, Boykin DW, Stephens CE, Anbazhagan M, Hall JE (2005) Unusual dehydroxylation of antimicrobial amidoxime prodrugs by cytochrome b5 and NADH cytochrome b5 reductase. Drug Metab Dispos 33:1886–1893PubMed
23.
Zurück zum Zitat Tsan MPA (1975) Stimulation by propylthiouracil of the hexose monophosphate shunt in human polymorphonuclear leucocytes during phagocytosis. Br J Haematol 31:193–208PubMed Tsan MPA (1975) Stimulation by propylthiouracil of the hexose monophosphate shunt in human polymorphonuclear leucocytes during phagocytosis. Br J Haematol 31:193–208PubMed
24.
Zurück zum Zitat Wing S, Fantus I (1987) Adverse immunologic effects of antithyroid drugs. CMAJ 136:121–127PubMed Wing S, Fantus I (1987) Adverse immunologic effects of antithyroid drugs. CMAJ 136:121–127PubMed
25.
Zurück zum Zitat Hallengren B, Melander A, Thesleff S (1984) Local anaesthesia and immunomodulatory effects of antithyroid drugs. Acta Endocrinol (Copenh) 106:336–337 Hallengren B, Melander A, Thesleff S (1984) Local anaesthesia and immunomodulatory effects of antithyroid drugs. Acta Endocrinol (Copenh) 106:336–337
26.
Zurück zum Zitat Hallengren B, Forsgren A, Melander A (1980) Effects of antithyroid drugs on lymphocyte function in vitro. J Clin Endocrinol Metab 51:298–301PubMedCrossRef Hallengren B, Forsgren A, Melander A (1980) Effects of antithyroid drugs on lymphocyte function in vitro. J Clin Endocrinol Metab 51:298–301PubMedCrossRef
27.
Zurück zum Zitat Kariya K, Lee E, Hirouchi M (1984) Relationship between leukopenia and bone marrow myeloperoxidase in the rat treated with propylthiouracil. Jpn J Pharmacol 36:217–222PubMed Kariya K, Lee E, Hirouchi M (1984) Relationship between leukopenia and bone marrow myeloperoxidase in the rat treated with propylthiouracil. Jpn J Pharmacol 36:217–222PubMed
28.
Zurück zum Zitat Iitaka M, Iwatani Y, Gerstein H, Row V, Volpe R (1987) Immunomodulatory effect of the treatment of Graves’ disease on antigen-specific monocyte procoagulant activity production. Clin Endocrinol (Oxf) 27:321–330 Iitaka M, Iwatani Y, Gerstein H, Row V, Volpe R (1987) Immunomodulatory effect of the treatment of Graves’ disease on antigen-specific monocyte procoagulant activity production. Clin Endocrinol (Oxf) 27:321–330
29.
Zurück zum Zitat Wilson R, McKillop J, Chopra M, Thomson J (1988) The effect of antithyroid drugs on B and T cell activity in vitro. Clin Endocrinol (Oxf) 28:389–397 Wilson R, McKillop J, Chopra M, Thomson J (1988) The effect of antithyroid drugs on B and T cell activity in vitro. Clin Endocrinol (Oxf) 28:389–397
30.
Zurück zum Zitat Ferguson M, McDonald F, Alexander W (1985) Inhibition of NK cell-induced cytolysis by thiocarbamide antithyroid drugs. Immunol Lett 11:117–120PubMedCrossRef Ferguson M, McDonald F, Alexander W (1985) Inhibition of NK cell-induced cytolysis by thiocarbamide antithyroid drugs. Immunol Lett 11:117–120PubMedCrossRef
Metadaten
Titel
Long-term propylthiouracil use and acute myeloid leukemia: A case report and review of the literature
verfasst von
Daniele Focosi
Francesco Caracciolo
Sara Galimberti
Federico Papineschi
Mario Petrini
Publikationsdatum
01.03.2008
Verlag
Springer-Verlag
Erschienen in
Annals of Hematology / Ausgabe 3/2008
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-007-0369-4

Weitere Artikel der Ausgabe 3/2008

Annals of Hematology 3/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.